ANALYTICAL E MODULE 03739040001

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05,06 report with the FDA on 2012-01-23 for ANALYTICAL E MODULE 03739040001 manufactured by Roche Diagnostics.

Event Text Entries

[19927163] The customer received questionable insulin results on their modular e170 analyzer. On (b)(6) 2011, the patient was taken to the hospital for low blood glucose shock. After this, the patient stopped using insulin. All the results provided were from fasting samples. Of the data provided, the results for the sample from (b)(6) 2012 are considered discrepant. The patient's first sample taken on (b)(6) 2011 and tested on (b)(6) 2011 had an insulin result of 2113 pmol/l. The patient's second sample taken (b)(6) 2011 had an insulin result of 1493 pmol/l on the e170 analyzer. The patient's third sample taken on (b)(6) 2012 had an insulin result of 1383. 5 pmol/l on the e170 analyzer. On (b)(6) 2012, the third sample was repeated on the e170 analyzer and the result was 1335 pmol/l. The sample was then diluted 1:10 and the result was 1540 pmol/l. On (b)(6) 2012, the third sample was tested on a siemens advia centaur and the result was 202. 13 pmol/l. The results from the e170 analyzer were reported outside the laboratory. A ct scan was administered to the patient to determine why the patient had such high insulin levels even after he stopped taking insulin. The patient's current condition is stable. There were no adverse events from the discrepant results. The insulin reagent lot number was 162791 and the expiration date was not provided.
Patient Sequence No: 1, Text Type: D, B5


[20274789] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[22132028] Without the sample for investigation, the root cause could not be determined. The calibration and quality control data provided were well within specification, no issue with the reagent is evident. It is possible there were antibodies to insulin present, which is not uncommon in people treated for a long time with bovine, porcine, and human insulin. The possible antibody interferences are listed in the package insert.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2012-00386
MDR Report Key2425267
Report Source01,05,06
Date Received2012-01-23
Date of Report2012-04-20
Date of Event2012-01-03
Date Mfgr Received2012-01-04
Date Added to Maude2012-01-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA JENNIFER WOLFGRAM
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175217008
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA NA
Manufacturer CityIBARAKI 312-8504
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameANALYTICAL E MODULE
Generic NameIMMUNOCHEMISTRY ANALYZER
Product CodeCFP
Date Received2012-01-23
Model NumberNA
Catalog Number03739040001
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2012-01-23

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.